CRA News

Ken Beers joins CRA's Life Sciences Practice as Vice President

September 20, 2022
Office building at night with illuminated windows

CRA is proud to welcome Kenneth J. Beers as a vice president in the Life Sciences Practice.

Mr. Beers supports biopharmaceutical clients across a range of topics involving development and commercialization of novel therapies, portfolio management, and business unit strategy. His 15 years of industry experience spans therapeutic areas and modalities on early-stage, pre-commercialization, and in-line therapies, as well as the integration of technologies such as diagnostics, software-as-a-medical-device, and bioinformatics.

“We look forward to working with Ken to address our clients’ most complex challenges,” said CRA’s Life Sciences Practice Leader and Vice President, Gregory K. Bell. “Ken brings an impressive set of skills to the team; in addition to supporting asset, portfolio, and business unit strategies for biopharmaceutical clients, we look forward to the focus he will bring to our continuing development of advanced analytics and strategic insights.”

Prior to joining CRA, Mr. Beers was a partner in an analytics company specializing in biopharma, medtech, and healthcare. He was previously the CEO of INTUS, a drug development platform that leverages proprietary biological network models to accelerate drug discovery.

Before starting his consulting career, Mr. Beers was an assistant professor of chemical engineering at the Massachusetts Institute of Technology. Mr. Beers holds a Bachelor of Chemical Engineering from Purdue University and a Ph.D. in Chemical Engineering from the University of Wisconsin-Madison.

Key contacts